Manufacturers of medicines, including Pfizer and Eli Lilly, have spent a combined $450,000 lobbying against price caps on ...

South Korea allocated 5.2% of its GDP to R&D in 2024. Increasing public and private research and development (R&D) ...

Human uptake of microplastic particles (MPs) is causing increasing health concerns, and there is mounting pressure to evaluate the associated risks. While MPs can be ingested, breathed in, or drank in ...

Earlier, Chairman Shin Dong-guk stated in an interview with Chosunilbo, 'Hanmi Pharmaceutical should continue under CEO Park Jae-hyun, while Hanmi Science should move towards ... of the Korea Adva ...

Business Editor Alan Healy reports on Ireland's enduring appeal as a location for US firms to set up shop — despite a ...

Michigan State University College of Human Medicine Dean Aron Sousa warns NIH funding cuts could halt research work in Grand ...

Lim Jong-yoon appointed president of Beijing Hanmi Pharmaceutical Lim Jong-yoons leadership marks a pivotal transition at ...

As the demand for novel therapies and personalized medicine surges, leaders are uniquely positioned to create a culture of creativity, collaboration and innovation.

Alcami Corporation, a contract development and manufacturing organization (CDMO), has appointed pharmaceutical industry ...

Intra-ImmuSG seeks to develop a safer and more effective cancer therapy via a combination of a targeted therapy and immunotherapy.

GSK is moving out of its 635K SF footprint at 14200 Shady Grove Road, where it is the sole tenant, just before its lease ...

No Safety Concerns Identified by DSMC in the ORCA-OL Long-Term Exposure Trial. Achieve Reiterates Planned Cytisinicline NDA Submission in Q2 2025. SEATTLE and VANCOUVER, British C ...